Skip to content
House introduces bill to reauthorize PPRV
Before heading home for President’s Day recess, Members of Congress made progress on a few priorities for the biotech industry. Of note, the House […]
House introduces bill to reauthorize PPRV Read More »
Federal Policy
USDA forum puts focus on biotech for sustainable farming
Encouraging farmers to use biotech and other climate tech to make agriculture more sustainable requires ensuring that their impact on climate is measured accurately
USDA forum puts focus on biotech for sustainable farming Read More »
GSK survey shows optimism for the future of biotech innovation
GSK believes that “innovation starts when we stop to listen.” In 2023, GSK took a moment to engage with a variety of people across
GSK survey shows optimism for the future of biotech innovation Read More »
BIO comments on NIST proposal to use march-in rights for price controls
Contention over the Bayh-Dole march-in rights provision is in the news again. The National Institute of Standards and Technology (NIST) proposes using the process
BIO comments on NIST proposal to use march-in rights for price controls Read More »
Black History Month: the policymakers & government leaders advancing biotech
Breakthroughs in biotech involve collaboration at every level. While entrepreneurial innovation is often the most visible, it’s policymaking and government leadership that lays the
Black History Month: the policymakers & government leaders advancing biotech Read More »
Legislation on PBM reform, preventive care advances in House
Tuesday, Feb. 6 was a busy day on Capitol Hill for health legislation. Two bills advanced through committees. The House Oversight & Investigations Committee
Legislation on PBM reform, preventive care advances in House Read More »
EPIC Act would fix IRA’s ‘pill penalty’ for small molecule drugs
A bipartisan amendment to the Inflation Reduction Act (IRA), introduced in the House on January 31, would fix the law’s small molecule “pill penalty”
EPIC Act would fix IRA’s ‘pill penalty’ for small molecule drugs Read More »
House passes bill restoring full R&D expensing
On January 31, the House passed legislation to restore the immediate expensing of R&D expenses. The Biotechnology Innovation Organization (BIO) has long advocated for
House passes bill restoring full R&D expensing Read More »
Congressional action BIO wants to see in 2024
As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year. BIO’s
Congressional action BIO wants to see in 2024 Read More »
CDC report: up-to-date COVID-19 vaccinations can protect against severe outcomes
Four years after the start of the pandemic, it is well known that COVID-19 is linked with thrombosis. A new report from the Centers
CDC report: up-to-date COVID-19 vaccinations can protect against severe outcomes Read More »